デフォルト表紙
市場調査レポート
商品コード
921944

病理解剖の世界市場:成長・動向・予測

Anatomic Pathology Market - Growth, Trends, and Forecast (2020 - 2025)

出版日: | 発行: Mordor Intelligence Pvt Ltd | ページ情報: 英文 111 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.72円
病理解剖の世界市場:成長・動向・予測
出版日: 2020年01月01日
発行: Mordor Intelligence Pvt Ltd
ページ情報: 英文 111 Pages
納期: 2~3営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の病理解剖市場を調査し、市場の概要、製品・サービス・用途・エンドユーザー別の市場規模の推移と予測、市場の成長要因および阻害要因、市場機会、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 イントロダクション

  • 調査成果
  • 調査の前提条件
  • 調査範囲

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場概況
  • 市場の成長要因
    • がんなどの標的疾患の罹患率の高さ
    • オーダーメイド医療への注目の高まり
    • 先進病理学機器の使用率の高さ
  • 市場の阻害要因
    • 病理解剖に関する政府の厳しい規制
    • 熟練した専門家の不足
  • ファイブフォース分析
    • 買い手の交渉力
    • 供給企業の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係

第5章 市場セグメンテーション

  • 製品・サービス別
    • 装置
    • 消耗品
    • サービス
  • 用途別
    • 疾病診断
    • 創薬・開発
    • その他
  • エンドユーザー別
    • 病院
    • 研究所
    • 診断研究所
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • Thermo Fisher Scientific Inc.
    • Quest Diagnostics Incorporated
    • Laboratory Corporation of America Holdings
    • F. Hoffmann-La Roche Ltd.
    • Agilent Technologies, Inc.
    • Cardinal Health
    • Sakura Finetek USA, Inc.
    • NeoGenomics Laboratories, Inc.
    • BioGenex
    • Bio SB

第7章 市場機会および将来動向

目次
Product Code: 67761

Market Overview

The anatomic pathology market will show rapid growth due to the high incidence of cancer and other target diseases, growing focus on personalized medicine and a substantial number of supporting programs and training modules by government.

There is rapid growth in the geriatric population and the increasing incidence rate of cancer and other chronic diseases. Rising cases of chronic disease and increasing requirements to address the timely diagnosis of medical conditions are driving the market.

Due to the rapid increase in the prevalence of cancer, there is increasing usage of advanced pathology equipment such as staining systems, gross imaging, and digital microscopes that are poised to improve anatomic pathological practices to some extent. Digital imaging solutions also offer specificity and accuracy-related benefits over conventional techniques, which in turn, boosts the service uptake rate in the overall market.

In addition, growing awareness and an increase in the patient pool in developing countries is also driving the growth of the market. Moreover, the increase in healthcare expenditure and the increase in usage of biomarkers during disease diagnosis are also found driving the market.

Scope of the Report

As per the scope of the report, anatomic pathology is a medical specialty that is concerned with the diagnosis of disease based on the microscopic, macroscopic, biochemical, immunologic and molecular examination of organs and tissues. Anatomic pathology involves visualization of human tissue under a microscope for proper diagnosis of the disease or a pathological condition. Microscopic examination of tissue samples with the help of one or more stains is a standard procedure performed in anatomic pathology.

Key Market Trends

Hospitals Segment is Expected to Dominate the Anatomic Pathology Market During the Forecast Period

Hospitals are expected to dominate the market owing to the high hospitalization rate of cancer patients, coupled with a substantial number of frequent readmissions in hospitals. Moreover, the presence of well-developed infrastructure, as well as well-trained staff in hospital-based pathological laboratories, stimulates the progression of the hospital segment. The segment is also expected to benefit from an increasing number of initiatives undertaken by public and private agencies to promote advanced healthcare systems.

On the other side, a large number of clinical trials through various ongoing projects have spurred the progression of the research laboratories segment. Research laboratories are engaged in offering rapid and comprehensive information about the functioning of diseased tissues, with an overall objective of achieving a high degree of patient satisfaction that is expected to grow in the upcoming future.

North America is Found Leading the Anatomic Pathology Market

North America has been accounted for the largest revenue share due to the presence of major players and supportive government initiatives pertaining to training pathological programs. There is also easy accessibility to advanced technologies, government initiatives for screening cancer patients, favorable reimbursement scenario for anatomic pathology diagnostic tests, increasing healthcare expenditure, and the presence of high-quality infrastructure for hospitals and clinical laboratories in the region that are the major factors driving the growth of the market in North America.

Competitive Landscape

Product innovation and ongoing R&D activities to develop advanced technologies have helped in boosting the growth of the market. Various strategies and collaborations are being adopted by these key players to maintain their market share. The key players are found implementing multiple strategies to maintain their significant share in the marketplace during the forecast period. The strategies implemented include collaborative development, business expansion, and product developments.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 High Incidence of Cancer and Other Target Diseases
    • 4.2.2 Growing Focus on Personalized Medicine
    • 4.2.3 High Usage of Advanced Pathology Equipment
  • 4.3 Market Restraints
    • 4.3.1 Stringent Government Regulations Pertaining to Anatomic Pathology
    • 4.3.2 Lack of Skilled Professionals
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product & Services
    • 5.1.1 Instruments
    • 5.1.2 Consumables
    • 5.1.3 Services
  • 5.2 By Application
    • 5.2.1 Disease Diagnosis
    • 5.2.2 Drug Discovery and Development
    • 5.2.3 Others
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Research Laboratories
    • 5.3.3 Diagnostic Laboratories
    • 5.3.4 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Thermo Fisher Scientific Inc.
    • 6.1.2 Quest Diagnostics Incorporated
    • 6.1.3 Laboratory Corporation of America Holdings
    • 6.1.4 F. Hoffmann-La Roche Ltd.
    • 6.1.5 Agilent Technologies, Inc.
    • 6.1.6 Cardinal Health
    • 6.1.7 Sakura Finetek USA, Inc.
    • 6.1.8 NeoGenomics Laboratories, Inc.
    • 6.1.9 BioGenex
    • 6.1.10 Bio SB

7 MARKET OPPORTUNITIES AND FUTURE TRENDS